10-Q: Q3 2024 Earnings Report

SECNov 15 05:46 · Announcements

8-K: Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

SECNov 15 05:29

Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit

Fortress Biotech Inc Series A POct 9 12:00

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

GlobeNewswireSep 20 20:30

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Fortress Biotech Inc Series A PSep 9 12:00

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswireSep 4 20:30